Diabetes Diagnostics Market: Global Industry Analysis and Forecast (2022-2029)


Diabetes Diagnostics Market size was valued at US$ 26.70 Bn in 2021 and the total revenue is expected to grow at 7.8 % through 2021 to 2029, reaching nearly US$ 48.69 Bn.

Global Diabetes Diagnostics Market Overview:

The global diabetes diagnostics market is estimated at US$ 26.70 Billion in 2021, and it is expected to reach US$ 48.69 Billion by 2029, growing at a CAGR of 7.8 % over the forecast period of 2022-2029.

Global Diabetes Diagnostics Market

To know about the Research Methodology :- Request Free Sample Report

Driven by the expanding frequency of diabetes, the global diabetes diagnostics market is displaying striking growth. As per the World Health Association (WHO), 422 million people are suffering from diabetes disease. Diabetes is higher in low-and middle-income counties; according to the WHO's discoveries, diabetes additionally is distinguished as a chief purpose for rising kidney failure, visual deficiency, Heart-attack, stroke, and lower appendage removal cases. As per the WHO, 1.9 billion adults aged 18 years and older were overweight in 2021. So the demand for better performance and smarter diabetes diagnosis is needed.

Global Diabetes Diagnostics Market Dynamics:

Increased awareness of preventive consideration and innovative factors are helpful for the driving diabetes diagnostics market. Patients are utilizing computer-based applications which can connect with these smart blood glucose monitoring devices. To manage patients' requirements, there are numerous administration drives and learning stages. For Example, with one year of limitless admittance to ensure diabetes mentors, Educated Information Frameworks Inc. one drop launched a glucose monitoring system in 2021. Patients are also using a glucose monitoring device for their diagnosis efficiently. Governments are increasing funding in healthcare sector and private hospitals.

In 2021, as indicated by UK National Health Service (NHS), almost 4.6 million people have diabetes, and more than 670,000 people were unconscious and undiscovered. This may limit the market growth.

Diabetes diagnostics play an important role in performing the test and diagnosis of the disease. Countries like Asia and Africa have a gap between the supply and demand of manufacturers may challenges for the market.

Global Diabetes Diagnostics Market Segment Analysis:

The global diabetes diagnostics market is segmented into product, and end-user.

Based on the product, the global diabetes diagnostic market is sub-segmented into BGM Devices, Continuous Glucose Monitoring Devices, and Insulin Delivery Devices.

The insulin delivery device has held a large share having xx% in 2021. Factors attributing to the segment's growth are rising adoption of insulin pumps, improved patient satisfaction and adherence, and technological advancement. Additionally, this device is user-friendly, and the comfort of injection makes insulin easier. Due to ease of use of this device and flexibility of incorporating insulin injections into busy lifestyle may improve diabetes control with fewer efforts. Due to all these reasons, the demand for insulin delivery devices is increased.

The BGM (blood glucose monitoring) held a second-large share of xx% in 2021. Rising awareness about diabetes devices and technological advancement, high usage, and low cost, get a quick response with accurate diagnostics. The newest devices display blood glucose readings on a screen, so you can see the result in real-time, whether blood glucose levels are rising or falling.

Based on an end-User, the global diabetes diagnostic market is sub-segmented into Hospitals, Homecare, and Diagnostic Centers. According to the MMR report, the hospital segment held the largest market share having 45% in the year 2021. The hospital segment is expected to grow fast rate of xx% during the forecast period. Due to increasing the number of private hospitals and raising the number of patients, due to trained staff, good equipment, and good facilities, many people choose hospitals for their operation due to all these factors demands of the hospital segment are increasing rapidly.

 

Global Diabetes Diagnostics Market Regional Insights:

North America has the biggest diabetes diagnostics market in the world; it held xx% of the share in the year 2021, owing to the increasing number of patients and a favourable reimbursement scenario. According to WHO, 48 million people in North America are suffering from diabetes disease in 2021 and the number is expected to reach 63 million by 2045. In December 2021, Companion Medical Launched Inpen, its first smart insulin pen system in the U.S., is the FDA-supported system that can consolidate insulin injector pen with a smart application.

In 2021, APAC held the second-largest market share, xx% of the global market, owing to rising good strategies, increased convenience, a shift towards high-calorie energy-rich foods, changing lifestyles, and raising awareness about diabetes devices drives. Government drives and educational projects are likewise moving the market during the forecasting period. For example, Novo Nordisk alongside the Medical services in a local area, dispatched an awareness segment in 2017. MEA has the least market share had xx% of a share in 2021, owing to the population difference its cause the less demand for diabetes diagnostics.

Recent Development:

• In January 2021, Tandem Diabetes launched its t: slim X2 insulin pump with control-IQ technology, which combines the Dexcom G6 BGM with an insulin pump to regulate insulin level with little user effort.

• In February 2021, The Dexcom G6 is approved as both a standalone BGM and for integration with an automated insulin dosing system.

The objective of the report is to present a comprehensive analysis of the global Diabetes Diagnostics market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the global Diabetes Diagnostics market dynamics, structure by analyzing the market segments and project the global Diabetes Diagnostics market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Diabetes Diagnostics market make the report investor’s guide.

Global Diabetes Diagnostics Market Scope: Inquire before buying






Global Diabetes Diagnostics Market




Report Coverage
Details




Base Year:
2021
Forecast Period:
2022-2029




Historical Data:
2017 to 2021
Market Size in 2021:
US $ 26.70 Bn.




Forecast Period 2022 to 2029 CAGR:
7.8%
Market Size in 2029:
US $ 48.69Bn.




 Segments Covered:
by Product
• BGM Devices
• Continuous Glucose Monitoring Devices
• Insulin Delivery




by End-User
• Hospitals
• Homecare
• Diagnostic Centers






Global Diabetes Diagnostics Market, by Region

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America

Global Diabetes Diagnostics Market Key Players

• A.Menarini Diagnostics Ltd.
• Abbott Diabetes Care, Inc.
• Acon Laboratories, Inc.
• AgaMatrix, Inc.
• Apex Biotechnology Corporation
• ARKRAY, Inc.
• Ascensia Diabetes Care Holdings AG
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• BIONIME Corporation
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Beckman Coulter, Inc.
• HemoCue® AB
• DexCom, Inc.
• Diazyme Laboratories Inc.
• EKF Diagnostics Holdings Plc
• LifeScan, Inc.
• Medtronic PLC
• Nova Biomedical Corporation
• OSANG Healthcare Co., Ltd.
• Roche Diabetes Care, Inc.
• Sanofi S.A.
• Sanwa Kagaku Kenkyusho Co, Ltd.
• Siemens Healthineers
• Sinocare, Inc.
• PTS Diagnostics
• Trividia Health, Inc.
• TaiDoc Technology Corporation
• Tandem Diabetes Care, Inc.
• Terumo Corporation
• Tosoh Bioscience, Inc.
• Trinity Biotech plc

Frequently Asked Questions:

1. Which region has largest share in diabetes diagnostics Market?
Ans: North America holds highest share in 2021.

2. What is the growth rate of diabetes diagnostics Market?
Ans: The diabetes diagnostics Market is growing at a CAGR of 7.8 % during forecasting period 2022-2029.

3. What segments are covered in diabetes diagnostics Market?
Ans: Global diabetes diagnostics Market is segmented based on Product, End-user and Region.

4. Who are the key players in diabetes diagnostics Market?
Ans: The important key players in the diabetes diagnostics market are A.Menarini Diagnostics Ltd., Abbott Diabetes Care, Inc., Acon Laboratories, Inc., AgaMatrix, Inc., Apex Biotechnology Corporation, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Becton, Dickinson and Company, BIONIME Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation, Beckman Coulter, Inc., HemoCue® AB, DexCom, Inc., Diazyme Laboratories Inc., EKF Diagnostics Holdings Plc, LifeScan, Inc., Medtronic PLC, Nova Biomedical Corporation, OSANG Healthcare Co., Ltd., Roche Diabetes Care, Inc., Sanofi S.A., Sanwa Kagaku Kenkyusho Co, Ltd., Care, Inc., Terumo Corporation, Tosoh Bioscience, Inc., Trinity Biotech plc.

5. What is the study period of this market?
Ans: The diabetes diagnostics Market is studied from 2021 - 2029. 




1. Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Diabetes Diagnostics Market Size, by Market Value (US$ Bn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis, 2020
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Diabetes Diagnostics Market
3.4. Geographical Snapshot of the Diabetes Diagnostics Market, By Manufacturer share
4. Global Diabetes Diagnostics Market Overview, 2021-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porters Five Forces Analysis
4.1.6.1. Threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. Threat of Substitute Products
4.1.6.5. Intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Global Diabetes Diagnostics Market
5. Supply Side and Demand Side Indicators
6. Global Diabetes Diagnostics Market Analysis and Forecast, 2021-2029
6.1. Global Diabetes Diagnostics Market Size & Y-o-Y Growth Analysis.
7. Global Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
7.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
7.1.1. BGM Devices
7.1.2. Continuous Glucose Monitoring Devices
7.1.3. Insulin Delivery
7.2. Devices Market Size (Value) Estimates & Forecast By End-User, 2021-2029
7.2.1. Hospitals
7.2.2. Homecare
7.2.3. Diagnostic Centers
8. Global Diabetes Diagnostics Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
9.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
9.1.1. BGM Devices
9.1.2. Continuous Glucose Monitoring Devices
9.1.3. Insulin Delivery
9.2. Devices Market Size (Value) Estimates & Forecast By End-User, 2021-2029
9.2.1. Hospitals
9.2.2. Homecare
9.2.3. Diagnostic Centers
10. North America Diabetes Diagnostics Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
11.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
11.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
12. Canada Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
12.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
12.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
13. Mexico Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
13.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
13.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
14. Europe Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
14.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
14.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
15. Europe Diabetes Diagnostics Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K. Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
16.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
16.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
17. France Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
17.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
17.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
18. Germany Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
18.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
18.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
19. Italy Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
19.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
19.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
20. Spain Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
20.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
20.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
21. Sweden Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
21.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
21.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
22. CIS Countries Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
22.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
22.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
23. Rest of Europe Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
23.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
23.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
24. Asia Pacific Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
24.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
24.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
25. Asia Pacific Diabetes Diagnostics Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
26.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
26.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
27. India Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
27.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
27.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
28. Japan Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
28.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
28.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
29. South Korea Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
29.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
29.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
30. Australia Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
30.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
30.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
31. ASEAN Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
31.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
31.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
32. Rest of Asia Pacific Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
32.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
32.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
33. Middle East Africa Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
33.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
33.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
34. Middle East Africa Diabetes Diagnostics Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
35.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
35.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
36. GCC Countries Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
36.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
36.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
37. Egypt Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
37.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
37.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
38. Nigeria Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
38.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
38.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
39. Rest of ME&A Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
39.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
39.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
40. South America Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
40.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
40.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
41. South America Diabetes Diagnostics Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
42.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
42.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
43. Argentina Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
43.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
43.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
44. Rest of South America Diabetes Diagnostics Market Analysis and Forecasts, 2021-2029
44.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
44.2. Market Size (Value) Estimates & Forecast By End-User, 2021-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Global Diabetes Diagnostics Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment
45.2.2. New Product Launches and Product Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
45.3. Company Profile : Key Players
45.3.1. A.Menarini Diagnostics Ltd.
45.3.1.1. Company Overview
45.3.1.2. Financial Overview
45.3.1.3. Geographic Footprint
45.3.1.4. Product Portfolio
45.3.1.5. Business Strategy
45.3.1.6. Recent Developments
45.3.2. Abbott Diabetes Care, Inc.
45.3.3. Acon Laboratories, Inc.
45.3.4. AgaMatrix, Inc.
45.3.5. Apex Biotechnology Corporation
45.3.6. ARKRAY, Inc.
45.3.7. Ascensia Diabetes Care Holdings AG
45.3.8. B. Braun Melsungen AG
45.3.9. Becton, Dickinson and Company
45.3.10. BIONIME Corporation
45.3.11. Bio-Rad Laboratories, Inc.
45.3.12. Danaher Corporation
45.3.13. Beckman Coulter, Inc.
45.3.14. HemoCue® AB
45.3.15. DexCom, Inc.
45.3.16. Diazyme Laboratories Inc.
45.3.17. EKF Diagnostics Holdings Plc
45.3.18. LifeScan, Inc.
45.3.19. Medtronic PLC
45.3.20. Nova Biomedical Corporation
45.3.21. OSANG Healthcare Co., Ltd.
45.3.22. Roche Diabetes Care, Inc.
45.3.23. Sanofi S.A.
45.3.24. Sanwa Kagaku Kenkyusho Co, Ltd.
45.3.25. Siemens Healthineers
45.3.26. Sinocare, Inc.
45.3.27. PTS Diagnostics
45.3.28. Trividia Health, Inc.
45.3.29. TaiDoc Technology Corporation
45.3.30. Tandem Diabetes Care, Inc.
45.3.31. Terumo Corporation
45.3.32. Tosoh Bioscience, Inc.
45.3.33. Trinity Biotech plc
46. Primary Key Insights
  • INQUIRE BEFORE BUYING